Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 17.85
+1.50 (9.17%)
Sep 5, 2025, 2:00 PM CST
Acepodia Revenue
Acepodia had revenue of 116.00K TWD in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 301.00K, down -98.22% year-over-year. In the year 2024, Acepodia had annual revenue of 427.00K, down -97.43%.
Revenue (ttm)
301.00K
Revenue Growth
-98.22%
P/S Ratio
34,961.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 427.00K | -16.17M | -97.43% |
| Dec 31, 2023 | 16.59M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Lumosa Therapeutics | 37.25M |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |